Literature DB >> 17651050

Comparison of image quality of different iodine isotopes (I-123, I-124, and I-131).

Erwann Rault1, Stefaan Vandenberghe, Roel Van Holen, Jan De Beenhouwer, Steven Staelens, Ignace Lemahieu.   

Abstract

I-131 is a frequently used isotope for radionuclide therapy. This technique for cancer treatment requires a pre-therapeutic dosimetric study. The latter is usually performed (for this radionuclide) by directly imaging the uptake of the therapeutic radionuclide in the body or by replacing it by one of its isotopes, which are more suitable for imaging. This study aimed to compare the image quality that can be achieved by three iodine isotopes: I-131 and I-123 for single-photon emission computed tomography imaging, and I-124 for positron emission tomography imaging. The imaging characteristics of each isotope were investigated by simulated data. Their spectrums, point-spread functions, and contrast-recovery curves were drawn and compared. I-131 was imaged with a high-energy all-purpose (HEAP) collimator, whereas two collimators were compared for I-123: low-energy high-resolution (LEHR) and medium energy (ME). No mechanical collimation was used for I-124. The influence of small high-energy peaks (>0.1%) on the main energy window contamination were evaluated. Furthermore, the effect of a scattering medium was investigated and the triple energy window (TEW) correction was used for spectral-based scatter correction. Results showed that I-123 gave the best results with a LEHR collimator when the scatter correction was applied. Without correction, the ME collimator reduced the effects of high-energy contamination. I-131 offered the worst results. This can be explained by the large amount of septal penetration from the photopeak and by the collimator, which gave a low spatial resolution. I-124 gave the best imaging properties owing to its electronic collimation (high sensitivity) and a short coincidence time window.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17651050     DOI: 10.1089/cbr.2006.323

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  12 in total

1.  Is PET always an advantage versus planar and SPECT imaging?

Authors:  Giuliano Mariani; Laura Bruselli; Adriano Duatti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08       Impact factor: 9.236

2.  Implementation of angular response function modeling in SPECT simulations with GATE.

Authors:  P Descourt; T Carlier; Y Du; X Song; I Buvat; E C Frey; M Bardies; B M W Tsui; D Visvikis
Journal:  Phys Med Biol       Date:  2010-04-14       Impact factor: 3.609

Review 3.  Novel Approaches to Thyroid Cancer Treatment and Response Assessment.

Authors:  Ravinder K Grewal; Alan Ho; Heiko Schöder
Journal:  Semin Nucl Med       Date:  2016-03       Impact factor: 4.446

Review 4.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

5.  The evolving role of nuclear molecular imaging in cancer.

Authors:  Ka Kurdziel; G Ravizzini; By Croft; Jl Tatum; Pl Choyke; H Kobayashi
Journal:  Expert Opin Med Diagn       Date:  2008-07

6.  Recurrent/metastatic thyroid carcinomas false negative for serum thyroglobulin but positive by posttherapy I-131 whole body scans.

Authors:  Eun-Kyung Park; June-Key Chung; Il Han Lim; Do Joon Park; Dong Soo Lee; Myung Chul Lee; Bo Youn Cho
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-09-09       Impact factor: 9.236

7.  False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer.

Authors:  Jong-Ryool Oh; Byeong-Cheol Ahn
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-10

8.  Sodium iodide symporter for nuclear molecular imaging and gene therapy: from bedside to bench and back.

Authors:  Byeong-Cheol Ahn
Journal:  Theranostics       Date:  2012-04-11       Impact factor: 11.556

9.  Comparison of Image Quality of Different Radionuclides Technetium-99m, Samarium-153, and Iodine-123.

Authors:  Youssef Bouzekraoui; Farida Bentayeb; Hicham Asmi; Faustino Bonutti
Journal:  Indian J Nucl Med       Date:  2019 Jul-Sep

Review 10.  Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX.

Authors:  Joseph Lau; Kuo-Shyan Lin; François Bénard
Journal:  Theranostics       Date:  2017-09-26       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.